课题基金 / 基金详情

The Vanderbilt Specialized Chemistry Center for Accelerated Probe Development

The Vanderbilt Specialized Chemistry Center for Accelerated Probe Development
范德比尔特专业化学中心加速探针开发
批准号:
8337390
负责人:
CRAIG LINDSLEY
金额:
$300.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-01 至 2014-05-31

项目摘要

项目成果

CRAIG LINDSLEY的其他基金

相似基金

相关文献

中文摘要
翻译
我们提议建立一个专门的化学中心--范德比尔特加速探针开发专门化学中心,以加快发现和开发高质量的探针化合物,这将对MLPCN研究网络的目标产生重大影响。在Lindsley技术支持的合成(TES)实验室和Conn实验室内的基础设施、资源和广泛的药物发现(从点击到引出到概念验证到临床)经验的基础上,我们准备与MLPCN网络中的外部专业筛选和综合中心合作支持探针开发项目。由于我们最先进的高通量药物化学技术平台和我们的硕士和博士级别的工作人员化学家,我们拟建的中心将能够支持五(5)个探针开发项目,内部或外部中心并行(约20个探针开发计划/年),并需要不到三个月的时间来开发用于体外和/或体内概念验证实验的探针和先进的分子工具。拟建的范德比尔特加速探针开发专门化学中心与其他中心的独特之处在于,PI在制药业拥有八年从点击到引线到概念验证的经验,并在范德比尔特内部按照行业标准建立了设备齐全的高通量合成和纯化实验室,允许最少的人力资源开发具有加速时间表的探针化合物。我们的初始目标将是提供符合或超过MPLCN指南和/或满足发起筛查的调查者的探针的特定要求的探针化合物。当与NIH/NIMH和MLPCN的目标保持一致时,我们将利用我们的MLPCN的一部分以及林德斯利和康恩实验室的内部资源(合成/药物化学、药理学、DMPK和放射化学)进行中心驱动的研究项目,以进一步提炼和开发治疗相关靶点的探针,以确保可以进行活体概念验证实验,以提供“快速杀死”或验证靶点作为潜在的治疗剂,以满足未满足的医疗需求。最后,我们将为MLPCN内的其他化学家提供培训假期,以学习并行合成技术和库设计策略。
英文摘要
We are proposing the establishment of a specialized chemistry center, the Vanderbilt Specialized Chemistry Center for Accelerated Probe Development, to expedite the discovery and development of high quality probe compounds which will significantly impact the goals of the MLPCN Research Network. Building on the infrastructure, resources and broad drug discovery (hit-to-lead-to-proof of concept-to-clinic) experience within the Lindsley Technology Enabled Synthesis (TES) Lab and the Conn Lab, we are poised to support probe development projects in collaboration with external Specialty Screening and Comprehensive Centers in the MLPCN Network. Due to our state-of-the-art technology platform for high-throughput medicinal chemistry and our M.S. and Ph.D. level staff chemists, our proposed center will be capable of supporting five (5) probe development projects, with internal or external centers, in parallel (~20 probe development programs/year) and require less than three months to develop probes and advanced molecular tools for in vitro and/or in vivo proof of concept experiments. The proposed Vanderbilt Specialized Chemistry Center for Accelerated Probe Development is unique from other centers in that the PI has eight years hit-to-lead-to-proof of concept experience in the pharmaceutical industry and has built a fully equipped high-throughput synthesis and purification lab, at the industry standard, within Vanderbilt which allows minimal human resources to develop probe compounds with expedited timelines. Our initial goal will be to deliver probe compounds that meet or exceed MPLCN guidelines and/or meet specific requirements for a probe of the investigator that initiated the screen. When aligned with NIH/NIMH and MLPCN goals, we will use a portion of our MLPCN and internal resources in the Lindsley and Conn Labs (synthesis/medicinal chemistry, pharmacology, DMPK and adiochemistry) in Center-Driven Research Projects to further refine and develop probes for therapeutically relevant targets to ensure in vivo proof of concept experiments can be performed to provide 'quick kills' or validate targets as potential therapeutic agents for unmet medical needs. Finally, we will offer training sabbaticals to other chemists within the MLPCN to learn parallel synthesis techniques and library design strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of mGlu7 receptor allosteric modulators for neurological and psychiatric disorders
  • 批准号:
    10426338
  • 项目类别:
  • 资助金额:
    $69.49万
  • 财政年份:
    2020
  • 负责人:
    CRAIG LINDSLEY
  • 依托单位:
Development of mGlu7 receptor allosteric modulators for neurological and psychiatric disorders
  • 批准号:
    10674501
  • 项目类别:
  • 资助金额:
    $69.77万
  • 财政年份:
    2020
  • 负责人:
    CRAIG LINDSLEY
  • 依托单位:
Development of mGlu7 receptor allosteric modulators for neurological and psychiatric disorders
  • 批准号:
    10093390
  • 项目类别:
  • 资助金额:
    $74.11万
  • 财政年份:
    2020
  • 负责人:
    CRAIG LINDSLEY
  • 依托单位:
Development of mGlu7 receptor allosteric modulators for neurological and psychiatric disorders
  • 批准号:
    10266776
  • 项目类别:
  • 资助金额:
    $69.51万
  • 财政年份:
    2020
  • 负责人:
    CRAIG LINDSLEY
  • 依托单位:
国内基金
海外基金
Handbook of the Mathematics of the Arts and Sciences的中文翻译
  • 批准号:
    12226504
  • 项目类别:
    数学天元基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2022
  • 负责人:
    黄朝凌
  • 依托单位:
ARTS在邻苯二甲酸(2-乙基己基)酯诱导的小鼠睾丸间质细胞凋亡中的作用及机理研究
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    35万元
  • 批准年份:
    2020
  • 负责人:
    陈加祥
  • 依托单位:
ARTS在邻苯二甲酸(2-乙基己基)酯诱导的小鼠睾丸间质细胞凋亡中的作用及机理研究
  • 批准号:
    82060278
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    35.0万元
  • 批准年份:
    2020
  • 负责人:
    陈加祥
  • 依托单位:
促进肿瘤凋亡的融合蛋白CPP-TRAIL-ARTS C27的制备及机制研究
  • 批准号:
    81372444
  • 项目类别:
    面上项目
  • 资助金额:
    70.0万元
  • 批准年份:
    2013
  • 负责人:
    易成
  • 依托单位: